Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...

FORT WORTH, Texas, Dec. 17, 2025 /PRNewswire/ -- NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of David Arthur as Chief Executive Officer. This appointment reflects ...

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo Fisher Scientific Inc., the world leader in ...

HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, announced HKEY-AIRx1.0, a translational preclinical ...

Today's article presents why Amneal should get my prior buy rating from September reaffirmed. Although some technical signals support a hold rather than bullishness, fundamental analysis shows several ...

Samsung Epis Holdings, the new holding company for Samsung Bioepis, is pursuing a bold expansion strategy focused on pipeline ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

Fannin Partners and Allterum Therapeutics, Inc. are pleased to announce that Brian Wipke, Ph.D., an accomplished immunologist and drug discovery and development leader with more than 20 years of ...

・AbbVie CEO said that the company is now looking at candidates that provide sustained weight loss. ・The obesity drug market is currently dominated by GLP-1 drugs such as Novo Nordisk’s Wegovy and Eli ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

FRANKFURT, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in ...